Innoviva, Inc. Banner Image

Innoviva, Inc.

  • Ticker INVA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Innoviva, Inc. Logo Image
  • 1-10 Employees
  • Based in Burlingame, California
Innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva's portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointlyMore developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible to receive associated royalty revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and, if approved and commercialized, VI monotherapy, as well. In addition, Innoviva retains a 15 percent economic interest in future payments made by GSK for earlier-stage programs partnered with Theravance BioPharma, Inc.
4.7 / 5.0 (193)

Innoviva, Inc. reports have an aggregate usefulness score of 4.7 based on 193 reviews.

Innoviva, Inc.

Most Recent Annual Report

Innoviva, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Innoviva, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!